IDiyas

For the Inventor, By the Inventor

Toyama, Japan

Tetsuo Yamafuji

USPTO Granted Patents = 11

Average Co-Inventor Count = 6.3

ph-index = 8

Forward Citations = 249(Granted Patents)


Location History:

  • Toyama, JP (1987 - 1999)
  • Toyama-ken, JP (1997 - 1999)
  • Nei-Gun, JP (2000)

Company Filing History:

goldMedal11 out of 159 
 
Toyama Chemical Co., Ltd.
 patents

Years Active: 1987-2000

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6153613 - 2,3-diketopiperazine derivatives or their salts (2000-11-28),
2. 5877174 - 2,3-diketopiperazine derivatives or their salts (1999-03-02),
3. 5872117 - 1,2-ethanediol derivative and salt thereof, process for producing the (1999-02-16),
4. 5719150 - 1,2-ethanediol derivative and salt thereof, process for producing the (1998-02-17),
5. 5658904 - 1,2-ethanediol derivative and salt thereof and cerebral (1997-08-19),
6. 5612381 - 1,2-ethanediol derivative and salt thereof process for producing the (1997-03-18),
7. 5472984 - 1,2-ethanediol derivative and salt thereof and cerebral (1995-12-05),
8. 5380878 - Benzo[b]thiophen-5-yl derivative and process for producing the same (1995-01-10),
9. 5280032 - 1,2-ethanediol derivative and salt thereof, process for producing the (1994-01-18),
10. 4851535 - Nicotinic acid derivatives (1989-07-25),
11. 4704459 - Process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine (1987-11-03),

Title: The Innovative Contributions of Tetsuo Yamafuji

Introduction

Tetsuo Yamafuji is a prominent inventor based in Toyama, Japan, celebrated for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Yamafuji's innovative work has had a remarkable impact on therapeutic applications, especially in platelet aggregation.

Latest Patents

Among his latest innovations are the 2,3-diketopiperazine derivatives and their salts. These inventions relate to compounds that exhibit inhibitory effects on platelet aggregation due to their antagonistic action on the glycoprotein IIb/IIIa receptor. This discovery opens avenues for new prophylactic and therapeutic agents useful in treating diseases associated with platelet aggregation. The general formula for these derivatives includes variables such as R1, R2, A, B, and Y, which represent specific chemical groups pivotal to their function.

Career Highlights

Yamafuji has built a notable career at Toyama Chemical Co., Ltd., where he continues to push the boundaries of scientific research and innovation. His work has garnered attention not only for its technical details but also for its potential to address significant health challenges.

Collaborations

In his journey, Tetsuo Yamafuji has collaborated with esteemed colleagues such as Satoshi Ono and Yozo Todo. Their combined expertise has been instrumental in refining and advancing their shared research projects, leading to groundbreaking developments in the pharmaceutical landscape.

Conclusion

Tetsuo Yamafuji's contributions to innovative pharmaceutical solutions demonstrate the power of invention in improving health outcomes. Through his patents and collaborations, he has established himself as a key figure in the realm of medical science, ensuring that his inventions will serve a vital purpose in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…